Showing results (521-530 of 589) with videos related to

Sort By:
Pageof 59
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Nature|July 22, 2026
Tertiary lymphoid structures harbour stem-like tumour-specific T cellsAlexander B Afeyan, Adi Nagler, Chloe R Tu, et al.
Molecular Cancer|March 16, 2024
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effectsYufei Wang, Alicia Buck, Brandon Piel, et al.
Nature Cancer|January 9, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinomaTejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
Future Oncology (London, England)|April 11, 2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?Hiten D Patel, Maneka Puligandla, Brian M Shuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trialNourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Pageof 59